A preservative free generic alternative to DuoNeb® (Ipratropium Bromide Bar Coded; Available in the following package configurations per box. Mylan Specialty: DuoNeb is indicated for the treatment of bronchospasm associated with COPD in patients requiring more than one. Prescription Drug Information: Duoneb. Ritedose Pharmaceuticals DUONEB- ipratropium bromide and albuterol sulfate solution. Ritedose.

Author: Arakazahn Melabar
Country: Uzbekistan
Language: English (Spanish)
Genre: Software
Published (Last): 2 October 2005
Pages: 369
PDF File Size: 19.12 Mb
ePub File Size: 6.29 Mb
ISBN: 425-1-44766-879-8
Downloads: 20480
Price: Free* [*Free Regsitration Required]
Uploader: Akik

Of the total number of subjects in clinical studies of DuoNeb, 62 percent were 65 and over, while 19 percent inswrt 75 and over. Albuterol is believed to work by activating adenylate cyclase, the enzyme responsible for generating cAMP, the intracellular mediator.

This risk may be more clinically significant with long-acting beta-agonists than with short-acting beta-agonists.

DuoNeb Inhalation Solution (Dey), Drug Reference Encyclopedia

Minor Potential QT insrrt has been reported in packafe case reports with metronidazole. DuoNeb should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, or within 2 weeks of discontinuation of such agents because the action of albuterol sulfate on the cardiovascular system may be potentiated.

Minor Beta-agonists should be used cautiously with procainamide. Although the plasma ipratropium concentrations were low average peak plasma concentration of Moderate The concomitant use of rasagiline and sympathomimetic agents was not allowed in pacakge studies; therefore, caution is advised during concurrent use of rasagiline and respiratory adrenergic agents e.

Minor Caution is advised with the concomitant use of tamoxifen and short-acting beta-agonists due to an increased risk of QT prolongation. Although there are no studies examining the effects of ranolazine in patients receiving other QT prolonging drugs, coadministration of such drugs may result in additive QT prolongation. Although inhaled ipratropium is only minimally absorbed into the systemic circulation, the effects of ipratropium may be additive to other udoneb medications.

Care should be taken not to spray albuterol; ipratropium in the eyes. Albuterol hypersensitivity, levalbuterol hypersensitivity, paradoxical bronchospasm. Each inaert vial insrrt 3 mg albuterol sulfate 2. The cAMP thus formed mediates the cellular responses. When administered by oral inhalation, however, ipratropium exhibits greater antimuscarinic activity on the pacmage smooth muscle; systemic effects are minimal.


Avoid concomitant use of arsenic trioxide with other drugs that may cause QT interval prolongation; discontinue or select an alternative drug that does not prolong the QT interval prior to starting arsenic trioxide therapy. Minor Concurrent use of macimorelin with short-acting beta-agonists may increase the risk of developing torsade de pointes-type ventricular tachycardia.

Ciprofloxacin should be used with caution in patients receiving drugs that prolong the QT interval. Effects Seen with Anticholinergic Drugs: The prime action of beta -adrenergic drugs is to stimulate adenyl cyclase, the enzyme that catalyzes the formation of cyclic-3′,5′-adenosine monophosphate cAMP from adenosine triphosphate ATP. An interruption of osimertinib therapy with dose reduction or discontinuation of therapy may be necessary if QT prolongation occurs.

The clinical significance of these findings is unknown.

Minor Beta-agonists should be used cautiously and with close monitoring with disopyramide. Beta agonists infrequently produce cardiovascular adverse effects, mostly with high doses or in the setting of beta-agonist-induced hypokalemia. Ketoconazole has been associated with prolongation of the QT interval.

Excessive doses particularly in the overdose setting or IV administration of haloperidol may be associated with a higher risk of QT prolongation. Each 3 mL vial of DuoNeb contains 3.

Mylan Worldwide

Minor Iloperidone has been associated with QT prolongation; however, torsade de pointes TdP has not been reported. Minor Granisetron has been associated with QT prolongation. The manufacturer recommends avoiding concurrent use of tetrabenazine with other drugs known to prolong QTc, such as beta-agonists.

Inhalation dosage oral inhalation; i.

Related Drug Information Drug Summary. The inhaler contains 60 puffs or puffs, equal to 60 doses or doses. Major Caution and close observation should be used when albuterol is used concurrently with other adrenergic sympathomimetics, administered by any route, to avoid potential for increased cardiovascular effects. Inhalation spray Combivent Respimat: Albuterol sulfate was not clastogenic in a human peripheral lymphocyte assay or in an AH1 strain mouse inzert assay.


Moderate Beta-agonists are commonly used in conjunction with aminophylline or theophylline therapy. DuoNeb is psckage to maximize the response to treatment in patients with chronic obstructive pulmonary disease COPD by reducing bronchospasm through two distinctly different mechanisms: Severe Halofantrine is considered to have a well-established risk for QT prolongation and torsade de pointes TdP. Minor Concomitant use may result in additive effects on the QT interval. To inhale a dose: Minor Telavancin has been associated with QT prolongation.

Albuterol sulfate has been shown to be teratogenic in mice.

PDR Search

Minor Due to the potential for QT interval prolongation with primaquine, caution is advised with other drugs that prolong the QT interval. If bronchospasm occurs, the albuterol; ipratropium inhalation should be discontinued immediately and appropriate treatment measures instituted. After the first fingolimod dose, overnight monitoring with continuous ECG in a medical facility is advised for patients taking QT prolonging drugs with a known risk of torsade de pointes TdP.

Beta-agonists should be administered with extreme caution to patients being treated with drugs known to prolong the QT interval because the action of beta-agonists on the cardiovascular system may be potentiated. Moderate Although ipratropium and glycopyrronium are minimally absorbed into the systemic circulation, there is the potential for additive anticholinergic effects if these drugs are administered together. In structures outside of the blood-brain barrier pineal and pituitary glandsalbuterol concentrations were found to be times those found in whole brain.

If romidepsin must be coadministered with another drug that prolongs the QT interval, appropriate cardiovascular monitoring precautions should be considered, such as the monitoring of serum electrolytes and the ECG at baseline and periodically during treatment. Stimulation of beta2-receptors on peripheral vascular smooth muscle can cause vasodilation and a modest decrease in diastolic blood pressure.

Major Racepinephrine is a sympathomimetic drug with agonist actions at both the alpha and beta receptors.